偏重的研究方向:乳腺癌 经验分享:邮件说的是 be assessed by an editor。看来才开始内审啊 Stage Start Date Under Review 2024-04-26 14:01:23 Under Editorial Consideration 2024-04-26 11:20:25 Initial QC 2024-04-24 05:43:45 Manuscript Submission 2024-04-24 05:14:24
Stage Start Date Under Editorial Consideration 2024/3/12 Under Review 2024/3/11 Under Editorial Consideration 2024/3/11 Initial QC 2024/3/7 Manuscript Submission 2024/3/5
偏重的研究方向:乳腺癌
经验分享:邮件说的是 be assessed by an editor。看来才开始内审啊
Stage Start Date
Under Review 2024-04-26 14:01:23
Under Editorial Consideration 2024-04-26 11:20:25
Initial QC 2024-04-24 05:43:45
Manuscript Submission 2024-04-24 05:14:24
57
Stage Start Date
Under Editorial Consideration 2023-10-18 12:49:26
Under Review 2023-10-18 05:25:13
Under Editorial Consideration 2023-10-17 09:02:03
Initial QC 2023-10-14 12:04:38
Manuscript Submission 2023-10-08 10:02:56
为什么我有2个编辑审核呢
88
审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向:非小细胞肺癌
经验分享:Stage Start Date
Under Editorial Consideration 2023-10-02 09:57:28
Under Review 2023-09-21 06:40:54
Under Editorial Consideration 2023-09-20 08:48:21
Initial QC 2023-09-18 13:01:13
Manuscript Submission 2023-09-18 10:44:07
110
偏重的研究方向:肿瘤;代谢
经验分享:Stage Start Date
Under Editorial Consideration 2024-02-26 07:11:31
Under Review 2024-02-23 12:33:32
Under Editorial Consideration 2024-02-23 12:12:07
Initial QC 2024-02-23 10:33:41
Manuscript Submission 2024-02-22 12:50:31
64
最近有幸接受一篇,投稿10月28,正式发表2月13,非常高效。就是不知道这个期刊的影响因子不知道2023年怎么样
66
Stage Start Date
Under Editorial Consideration 2024/3/12
Under Review 2024/3/11
Under Editorial Consideration 2024/3/11
Initial QC 2024/3/7
Manuscript Submission 2024/3/5
62
有两个Under Editorial Consideration是不是就是要凉凉了?
59
1
53
1
51
Under Editorial Consideration Under Review Under Editorial Consideration Initial QC Manuscript Submission 2024-02-05 08:28:08 2024-01-26 13:58:52 2024-01-26 09:56:58 2024-01-22 12:02:15 2024-01-22 08:33:06
67